FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eberhard Schlicker

Research Profile

Living Beings

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Hanna Kozłowska; Mirosław Kozłowski; Marta Baranowska-Kuczko; Monika Kloza; Eberhard Schlicker; Barbara Malinowska
Relaxation of human pulmonary arteries by PPARγ agonists.
Radosław Rudź; Urszula Baranowska; Piotr Karabowicz; Justyna Marciniak; Eberhard Schlicker; Barbara Malinowska
Acute myocardial infarction inhibits the neurogenic tachycardic and vasopressor response in rats via presynaptic cannabinoid type 1 receptor.
Kirsten Schulte; Nina Steingrüber; Andreas Zimmer; Rainer Buchalla; Bernd Jergas; Christina Maria Kurz; Beat Lutz; Agnes Redmer; Eberhard Schlicker
Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eberhard Schlicker (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hanna Kozłowska; Mirosław Kozłowski; Marta Baranowska-Kuczko; Monika Kloza; Eberhard Schlicker; Barbara Malinowska
Relaxation of human pulmonary arteries by PPARγ agonists.
Naunyn-Schmiedeberg's archives of pharmacology 2013;386(5):445-53.
2012: Radosław Rudź; Urszula Baranowska; Piotr Karabowicz; Justyna Marciniak; Eberhard Schlicker; Barbara Malinowska
Acute myocardial infarction inhibits the neurogenic tachycardic and vasopressor response in rats via presynaptic cannabinoid type 1 receptor.
The Journal of pharmacology and experimental therapeutics 2012;343(1):198-205.
2012: Kirsten Schulte; Nina Steingrüber; Andreas Zimmer; Rainer Buchalla; Bernd Jergas; Christina Maria Kurz; Beat Lutz; Agnes Redmer; Eberhard Schlicker
Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor.
Naunyn-Schmiedeberg's archives of pharmacology 2012;385(4):385-96.
2012: Barbara Malinowska; Marta Baranowska-Kuczko; Eberhard Schlicker
Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?
British journal of pharmacology 2012;165(7):2073-88.
2012: Hanna Kozłowska; Mirosław Kozłowski; Marta Baranowska-Kuczko; Emilia Grzęda; Eberhard Schlicker; Agnieszka Zakrzeska; Barbara Malinowska
EP₃ receptor-mediated contraction of human pulmonary arteries and inhibition of neurogenic tachycardia in pithed rats.
Pharmacological reports : PR 2012;64(6):1526-36.
2011: Sebastian Ł Lupiński; Anna Pędzińska-Betiuk; Eberhard Schlicker; Barbara Malinowska
Acute myocardial ischemia enhances the vanilloid TRPV1 and serotonin 5-HT3 receptor-mediated Bezold-Jarisch reflex in rats.
Pharmacological reports : PR 2011;63(6):1450-9.
2011: Kirsten Schulte; Manush Kumar; Jean-Marie Zajac; Eberhard Schlicker
Noradrenaline release in rodent tissues is inhibited by interleukin-1β but is not affected by urotensin II, MCH, NPW and NPFF.
Pharmacological reports : PR 2011;63(1):102-11.
2010: Agnieszka Zakrzeska; Eberhard Schlicker; Marta Baranowska; Hanna Kozłowska; Grzegorz Kwolek; Barbara Malinowska
A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats.
British journal of pharmacology 2010;160(3):574-84.
2010: J Günther; K Schulte; Daniela Wenzel; Barbara Malinowska; Eberhard Schlicker
Prostaglandins of the E series inhibit monoamine release via EP3 receptors: proof with the competitive EP3 receptor antagonist L-826,266.
Naunyn-Schmiedeberg's archives of pharmacology 2010;381(1):21-31.
2009: Cm Kurz; U Baranowska; S Lupiński; Manfred Göthert; Barbara Malinowska; Eberhard Schlicker
Urethane, but not pentobarbitone, attenuates presynaptic receptor function in rats: a contribution to the choice of anaesthetic.
British journal of pharmacology 2009;157(8):1474-82.
2009: Dorota Zelaszczyk; H Kozlowska; U Baranowska; M Baranowska; A Reutelsterz; Katarzyna Kiec-Kononowicz; Barbara Malinowska; Eberhard Schlicker
Four close bupranolol analogues are antagonists at the low-affinity state of beta1-adrenoceptors.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2009;60(1):51-60.
2008: Barbara Malinowska; S Lupinski; Grzegorz Godlewski; U Baranowska; Eberhard Schlicker
Role of endocannabinoids in cardiovascular shock.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2008;59 Suppl 8():91-107.
2008: H Kozłowska; Marta Baranowska; Eberhard Schlicker; M Kozłowski; J Laudañski; Barbara Malinowska
Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product.
British journal of pharmacology 2008;155(7):1034-42.
2008: Hester van Diepen; Eberhard Schlicker; Martin C Michel
Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716).
Naunyn-Schmiedeberg's archives of pharmacology 2008;378(4):345-69.
2008: C M Kurz; C Gottschalk; Eberhard Schlicker; Markus Kathmann
Identification of a presynaptic cannabinoid CB1 receptor in the guinea-pig atrium and sequencing of the guinea-pig CB1 receptor.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2008;59(1):3-15.
2008: Eberhard Schlicker; Markus Kathmann
Presynaptic neuropeptide receptors.
Handbook of experimental pharmacology 2008;(184):409-34.
2007: Hanna Kozłowska; Marta Baranowska; Eberhard Schlicker; Mirosław Kozłowski; Jerzy Laudański; Barbara Malinowska
Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery.
Journal of hypertension 2007;25(11):2240-8.
2007: Meliha Karsak; Evelyn Gaffal; Rahul Date; Lihua Wang-Eckhardt; Jennifer Rehnelt; Stefania Petrosino; Katarzyna Starowicz; Regina Steuder; Eberhard Schlicker; Benjamin F Cravatt; Urij Rampampam; Reinhard Buettner; Sabine Werner; Vincenzo Di Marzo; Thomas Tüting; Andreas Zimmer
Attenuation of allergic contact dermatitis through the endocannabinoid system.
Science (New York, N.Y.) 2007;316(5830):1494-7.
2006: Grzegorz Godlewski; Eberhard Schlicker; Urszula Baranowska; Barbara Malinowska
Recruitment of functionally active heart beta2-adrenoceptors in the initial phase of endotoxic shock in pithed rats.
Shock (Augusta, Ga.) 2006;26(5):510-5.
2006: H Kozłowska; Eberhard Schlicker; M Kozłowski; Marta Baranowska; Barbara Malinowska
Potential involvement of a propranolol-insensitive atypical beta-adrenoceptor the vasodilator effect of cyanopindolol in the human pulmonary artery.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2006;57(3):317-28.
2006: Markus Kathmann; Karsten Flau; Agnes Redmer; Christian Tränkle; Eberhard Schlicker
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors.
Naunyn-Schmiedeberg's archives of pharmacology 2006;372(5):354-61.
2005: Agnieszka Zakrzeska; Eberhard Schlicker; Grzegorz Kwolek; Hanna Kozłowska; Barbara Malinowska
Positive inotropic and lusitropic effects mediated via the low-affinity state of beta1-adrenoceptors in pithed rats.
British journal of pharmacology 2005;146(5):760-8.
2005: T Schultheiss; Karsten Flau; Markus Kathmann; Manfred Göthert; Eberhard Schlicker
Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta.
Naunyn-Schmiedeberg's archives of pharmacology 2005;372(2):139-46.
2005: Hanna Kozłowska; Eberhard Schlicker; Mirosław Kozłowski; Urszula Siedlecka; Jerzy Laudański; Barbara Malinowska
Ligands at beta2-, beta3-, and the low-affinity state of beta1-adrenoceptors block the alpha1-adrenoceptor-mediated constriction in human pulmonary and rat mesenteric arteries.
Journal of cardiovascular pharmacology 2005;46(1):76-82.
2005: Grzegorz Kwolek; Agnieszka Zakrzeska; Eberhard Schlicker; Manfred Göthert; Grzegorz Godlewski; Barbara Malinowska
Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats.
British journal of pharmacology 2005;145(5):567-75.
2005: Dorota Zelaszczyk; Agnieszka Zakrzeska; Grzegorz Kwolek; Barbara Malinowska; Eberhard Schlicker
A search for presynaptic beta3-adrenoceptors in the rat.
Fundamental & clinical pharmacology 2005;19(2):147-53.
2004: Holger Stark; Markus Kathmann; Eberhard Schlicker; Walter Schunack; Birgit Schlegel; Wolfgang Sippl
Medicinal chemical and pharmacological aspects of imidazole-containing histamine H3 receptor antagonists.
Mini reviews in medicinal chemistry 2004;4(9):965-77.
2004: Grzegorz Godlewski; Barbara Malinowska; Eberhard Schlicker
Presynaptic cannabinoid CB(1) receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats.
British journal of pharmacology 2004;142(4):701-8.
2003: Barbara Malinowska; Manfred Göthert; Edmund Przegaliński; Eberhard Schlicker
Report on the German-Polish symposium "Thirty years of cooperation between German and Polish pharmacologists. New perspectives in the Common Europe", Białowieza, September 18-21, 2003.
Polish journal of pharmacology 2003;55(5):807-10.
2003: Eberhard Schlicker; Agnes Redmer; Andre Werner; Markus Kathmann
Lack of CB1 receptors increases noradrenaline release in vas deferens without affecting atrial noradrenaline release or cortical acetylcholine release.
British journal of pharmacology 2003;140(2):323-8.
2003: Hanna Kozłowska; Urszula Szymska; Eberhard Schlicker; Barbara Malinowska
Atypical beta-adrenoceptors, different from beta 3-adrenoceptors and probably from the low-affinity state of beta 1-adrenoceptors, relax the rat isolated mesenteric artery.
British journal of pharmacology 2003;140(1):3-12.
2003: Barbara Malinowska; Katarzyna Kieć-Kononowicz; Karsten Flau; Grzegorz Godlewski; Hanna Kozłowska; Markus Kathmann; Eberhard Schlicker
Atypical cardiostimulant beta-adrenoceptor in the rat heart: stereoselective antagonism by bupranolol but lack of effect by some bupranolol analogues.
British journal of pharmacology 2003;139(8):1548-54.
2003: Agnes Redmer; Markus Kathmann; Eberhard Schlicker
Cannabinoid CB(1) receptor-mediated inhibition of hippocampal acetylcholine release is preserved in aged mice.
British journal of pharmacology 2003;138(8):1425-30.
2003: Susanna Liedtke; Karsten Flau; Markus Kathmann; Eberhard Schlicker; Holger Stark; Galina Meier; Walter Schunack
Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists.
Naunyn-Schmiedeberg's archives of pharmacology 2003;367(1):43-50.
2002: Karsten Flau; Agnes Redmer; S Liedtke; Markus Kathmann; Eberhard Schlicker
Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.
British journal of pharmacology 2002;137(8):1355-61.
2002: Barbara Malinowska; Grzegorz Godlewski; Eberhard Schlicker
Function of nociceptin and opioid OP4 receptors in the regulation of the cardiovascular system.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2002;53(3):301-24.
2001: B Weber; Eberhard Schlicker
Modulation of dopamine release in the guinea-pig retina by G(i)- but not by G(s)- or G(q)-protein-coupled receptors.
Fundamental & clinical pharmacology 2001;15(6):393-400.
2001: Eberhard Schlicker; Markus Kathmann
Modulation of transmitter release via presynaptic cannabinoid receptors.
Trends in pharmacological sciences 2001;22(11):565-72.
2001: Barbara Malinowska; J Piszcz; B Koneczny; A Hryniewicz; Eberhard Schlicker
Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptors.
Naunyn-Schmiedeberg's archives of pharmacology 2001;364(3):233-41.
2001: B Weber; Eberhard Schlicker; Pierre Sokoloff; Holger Stark
Identification of the dopamine autoreceptor in the guinea-pig retina as D(2) receptor using novel subtype-selective antagonists.
British journal of pharmacology 2001;133(8):1243-8.
2001: Eberhard Schlicker; H Kozłowska; Grzegorz Kwolek; Barbara Malinowska; K Kramer; Heinz H Pertz; Sigurd Elz; Walter Schunack
Novel histaprodifen analogues as potent histamine H1-receptor agonists in the pithed and in the anaesthetized rat.
Naunyn-Schmiedeberg's archives of pharmacology 2001;364(1):14-20.
2001: T Nickel; U Bauer; Eberhard Schlicker; Markus Kathmann; Manfred Göthert; A Sasse; Holger Stark; Walter Schunack
Novel histamine H(3)-receptor antagonists and partial agonists with a non-aminergic structure.
British journal of pharmacology 2001;132(8):1665-72.
2001: Markus Kathmann; B Weber; Andreas Zimmer; Eberhard Schlicker
Enhanced acetylcholine release in the hippocampus of cannabinoid CB(1) receptor-deficient mice.
British journal of pharmacology 2001;132(6):1169-73.
2001: Wolfgang Fischer; Holger Kittner; Ralf Regenthal; Barbara Malinowska; Eberhard Schlicker
Anticonvulsant and sodium channel blocking activity of higher doses of clenbuterol.
Naunyn-Schmiedeberg's archives of pharmacology 2001;363(2):182-92.
2001: Markus Kathmann; B Weber; Eberhard Schlicker
Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice.
Naunyn-Schmiedeberg's archives of pharmacology 2001;363(1):50-6.
2000: Barbara Malinowska; H Kozłowska; H Berger; Eberhard Schlicker
Acetyl-RYYRIK-NH(2) is a highly efficacious OP(4) receptor agonist in the cardiovascular system of anesthetized rats.
Peptides 2000;21(12):1875-80.
2000: Gerhard J Molderings; Sigrid Menzel; Markus Kathmann; Eberhard Schlicker; Manfred Göthert
Dual interaction of agmatine with the rat alpha(2D)-adrenoceptor: competitive antagonism and allosteric activation.
British journal of pharmacology 2000;130(7):1706-12.
2000: Eberhard Schlicker; M Morari
Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system.
Peptides 2000;21(7):1023-9.
2000: Barbara Malinowska; H Kozłowska; B Koneczny; Eberhard Schlicker
Nociceptin inhibits the neurogenic vasopressor response in the pithed rat via prejunctional ORL1 receptors.
Naunyn-Schmiedeberg's archives of pharmacology 2000;361(1):80-4.
2000: M Nakazi; U Bauer; T Nickel; Markus Kathmann; Eberhard Schlicker
Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors.
Naunyn-Schmiedeberg's archives of pharmacology 2000;361(1):19-24.
1999: Markus Kathmann; U Bauer; Eberhard Schlicker
CB1 receptor density and CB1 receptor-mediated functional effects in rat hippocampus are decreased by an intracerebroventricularly administered antisense oligodeoxynucleotide.
Naunyn-Schmiedeberg's archives of pharmacology 1999;360(4):421-7.
1999: Derek N Middlemiss; Manfred Göthert; Eberhard Schlicker; Claire M Scott; Julie V Selkirk; Jeannette Watson; Laramie M Gaster; Paul A Wyman; Graham Riley; Gary W Price
SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor.
European journal of pharmacology 1999;375(1-3):359-65.
1999: Markus Kathmann; U Bauer; Eberhard Schlicker; Manfred Göthert
Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain.
Naunyn-Schmiedeberg's archives of pharmacology 1999;359(6):466-70.
1999: S Werthwein; U Bauer; M Nakazi; Markus Kathmann; Eberhard Schlicker
Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro.
British journal of pharmacology 1999;127(1):300-8.
1999: Eberhard Schlicker; S Werthwein; Josef Zentner
Histamine H3 receptor-mediated inhibition of noradrenaline release in the human brain.
Fundamental & clinical pharmacology 1999;13(1):120-2.
1999: U Bauer; M Nakazi; Markus Kathmann; Manfred Göthert; Eberhard Schlicker
The stereoselective kappa-opioid receptor antagonist Mr 2266 does not exhibit stereoselectivity as an antagonist at the orphan opioid (ORL1) receptor.
Naunyn-Schmiedeberg's archives of pharmacology 1999;359(1):17-20.
1999: Barbara Malinowska; J Piszcz; Eberhard Schlicker; K Kramer; Sigurd Elz; W Schunack
Histaprodifen, methylhistaprodifen, and dimethylhistaprodifen are potent H1-receptor agonists in the pithed and in the anaesthetized rat.
Naunyn-Schmiedeberg's archives of pharmacology 1999;359(1):11-6.
1998: Markus Kathmann; Eberhard Schlicker; I Marr; S Werthwein; Holger Stark; Walter Schunack
Ciproxifan and chemically related compounds are highly potent and selective histamine H3-receptor antagonists.
Naunyn-Schmiedeberg's archives of pharmacology 1998;358(6):623-7.
1998: Eberhard Schlicker; S Werthwein; Markus Kathmann; U Bauer
Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors.
Naunyn-Schmiedeberg's archives of pharmacology 1998;358(4):418-22.
1998: Eberhard Schlicker; Manfred Göthert
Interactions between the presynaptic alpha2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones.
Brain research bulletin 1998;47(2):129-32.
1998: Barbara Malinowska; Grzegorz Godlewski; Eberhard Schlicker
Histamine H3 receptors--general characterization and their function in the cardiovascular system.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 1998;49(2):191-211.
1998: J Timm; I Marr; S Werthwein; Sigurd Elz; Walter Schunack; Eberhard Schlicker
H2 receptor-mediated facilitation and H3 receptor-mediated inhibition of noradrenaline release in the guinea-pig brain.
Naunyn-Schmiedeberg's archives of pharmacology 1998;357(3):232-9.
1997: Barbara Malinowska; Eberhard Schlicker
Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat.
British journal of pharmacology 1997;122(7):1307-14.
1997: Eberhard Schlicker; J Timm; Josef Zentner; Manfred Göthert
Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus.
Naunyn-Schmiedeberg's archives of pharmacology 1997;356(5):583-9.
1997: Eberhard Schlicker; Klaus Fink; Gerhard J Molderings; Gary W Price; Malcolm Duckworth; Laramie M Gaster; Derek N Middlemiss; Josef Zentner; James A Likungu; Manfred Göthert
Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors.
Naunyn-Schmiedeberg's archives of pharmacology 1997;356(3):321-7.
1997: Barbara Malinowska; Grzegorz Godlewski; B Bucher; Eberhard Schlicker
Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat.
Naunyn-Schmiedeberg's archives of pharmacology 1997;356(2):197-202.
1997: Eberhard Schlicker; I Marr
Mutual interactions of the presynaptic histamine H3 and prostaglandin EP3 receptors on the noradrenergic terminals in the mouse brain.
Neuroscience 1997;79(1):247-54.
1997: Grzegorz Godlewski; Barbara Malinowska; Eberhard Schlicker; B Bucher
Identification of histamine H3 receptors in the tail artery from normotensive and spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1997;29(6):801-7.
1997: Grzegorz Godlewski; Barbara Malinowska; W Buczko; Eberhard Schlicker
Inhibitory H3 receptors on sympathetic nerves of the pithed rat: activation by endogenous histamine and operation in spontaneously hypertensive rats.
Naunyn-Schmiedeberg's archives of pharmacology 1997;355(2):261-6.
1997: Eberhard Schlicker; K Fink; Markus Kathmann; Gerhard J Molderings; Manfred Göthert
Effects of imidazolines on noradrenaline release in brain: an investigation into their relationship to imidazoline, alpha 2 and H3 receptors.
Neurochemistry international 1997;30(1):73-83.
1996: Eberhard Schlicker; J Timm; Manfred Göthert
Cannabinoid receptor-mediated inhibition of dopamine release in the retina.
Naunyn-Schmiedeberg's archives of pharmacology 1996;354(6):791-5.
1996: Eberhard Schlicker; Klaus Fink; Josef Zentner; Manfred Göthert
Presynaptic inhibitory serotonin autoreceptors in the human hippocampus.
Naunyn-Schmiedeberg's archives of pharmacology 1996;354(3):393-6.
1996: Eberhard Schlicker; Markus Kathmann; H Bitschnau; I Marr; S Reidemeister; Holger Stark; Walter Schunack
Potencies of antagonists chemically related to iodoproxyfan at histamine H3 receptors in mouse brain cortex and guinea-pig ileum: evidence for H3 receptor heterogeneity?
Naunyn-Schmiedeberg's archives of pharmacology 1996;353(5):482-8.
1996: Barbara Malinowska; Eberhard Schlicker
Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.
British journal of pharmacology 1996;117(5):943-9.
1996: Eberhard Schlicker; I Marr
The moderate affinity of clozapine at H3 receptors is not shared by its two major metabolites and by structurally related and unrelated atypical neuroleptics.
Naunyn-Schmiedeberg's archives of pharmacology 1996;353(3):290-4.
1996: Manfred Göthert; Klaus Fink; D Frölich; James A Likungu; Gerhard J Molderings; Eberhard Schlicker; Josef Zentner
Presynaptic 5-HT auto- and heteroreceptors in the human central and peripheral nervous system.
Behavioural brain research 1996;73(1-2):89-92.
1995: Manfred Göthert; Gerhard J Molderings; Klaus Fink; Eberhard Schlicker
Alpha 2-adrenoceptor-independent inhibition by imidazolines and guanidines of noradrenaline release from peripheral, but not central noradrenergic neurons.
Annals of the New York Academy of Sciences 1995;763():405-19.
1995: Eberhard Schlicker; Heinz H Pertz; H Bitschnau; K Purand; Markus Kathmann; Sigurd Elz; Walter Schunack
Effects of iodoproxyfan, a potent and selective histamine H3 receptor antagonist, on alpha 2 and 5-HT3 receptors.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1995;44(7):296-300.
1995: Manfred Göthert; M Garbarg; J A Hey; Eberhard Schlicker; J C Schwartz; R Levi
New aspects of the role of histamine in cardiovascular function: identification, characterization, and potential pathophysiological importance of H3 receptors.
Canadian journal of physiology and pharmacology 1995;73(5):558-64.
1995: H J Exner; Eberhard Schlicker
Prostanoid receptors of the EP3 subtype mediate the inhibitory effect of prostaglandin E2 on noradrenaline release in the mouse brain cortex.
Naunyn-Schmiedeberg's archives of pharmacology 1995;351(1):46-52.
1994: Markus Kathmann; Eberhard Schlicker; Manfred Göthert
Intermediate affinity and potency of clozapine and low affinity of other neuroleptics and of antidepressants at H3 receptors.
Psychopharmacology 1994;116(4):464-8.
1994: Eberhard Schlicker; Markus Kathmann; S Reidemeister; Holger Stark; Walter Schunack
Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models.
British journal of pharmacology 1994;112(4):1043-8.
1994: Eberhard Schlicker; Markus Kathmann; M Detzner; H J Exner; Manfred Göthert
H3 receptor-mediated inhibition of noradrenaline release: an investigation into the involvement of Ca2+ and K+ ions, G protein and adenylate cyclase.
Naunyn-Schmiedeberg's archives of pharmacology 1994;350(1):34-41.
1994: M Detzner; Markus Kathmann; Eberhard Schlicker
Time course of the effects of histamine, thioperamide and EEDQ on H3 receptors in the mouse brain.
Agents and actions 1994;41 Spec No():C66-7.
1994: Klaus Fink; Eberhard Schlicker; Manfred Göthert
N-methyl-D-aspartate (NMDA)-stimulated noradrenaline (NA) release in rat brain cortex is modulated by presynaptic H3-receptors.
Naunyn-Schmiedeberg's archives of pharmacology 1994;349(2):113-7.
1994: Eberhard Schlicker; B Malinowska; Markus Kathmann; Manfred Göthert
Modulation of neurotransmitter release via histamine H3 heteroreceptors.
Fundamental & clinical pharmacology 1994;8(2):128-37.
1994: Eberhard Schlicker; Markus Kathmann; H J Exner; M Detzner; Manfred Göthert
The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide facilitates noradrenaline release by blockade of alpha 2-adrenoceptors in the mouse brain cortex.
Naunyn-Schmiedeberg's archives of pharmacology 1994;349(1):20-4.
1993: Markus Kathmann; Eberhard Schlicker; M Detzner; H Timmerman
Nordimaprit, homodimaprit, clobenpropit and imetit: affinities for H3 binding sites and potencies in a functional H3 receptor model.
Naunyn-Schmiedeberg's archives of pharmacology 1993;348(5):498-503.
1993: Eberhard Schlicker; B Malinowska; Markus Kathmann
CGP 35348 blocks noradrenaline-release-inhibiting GABAB receptors in the pig retina, rat vena cava and pithed rat vasculature.
Pharmacology 1993;47(2):111-6.
1993: Eberhard Schlicker; Klaus Fink; M Detzner; Manfred Göthert
Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors.
Journal of neural transmission. General section 1993;93(1):1-10.
1993: B Malinowska; Eberhard Schlicker
Identification of endothelial H1, vascular H2 and cardiac presynaptic H3 receptors in the pithed rat.
Naunyn-Schmiedeberg's archives of pharmacology 1993;347(1):55-60.
1992: Gerhard J Molderings; B Malinowska; Eberhard Schlicker
Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype.
British journal of pharmacology 1992;107(2):352-5.
1992: Gerhard J Molderings; G Weissenborn; Eberhard Schlicker; James A Likungu; Manfred Göthert
Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein by presynaptic histamine H3 receptors.
Naunyn-Schmiedeberg's archives of pharmacology 1992;346(1):46-50.
1992: Eberhard Schlicker; A Behling; G Lümmen; B Malinowska; Manfred Göthert
Mutual interaction of histamine H3-receptors and alpha 2-adrenoceptors on noradrenergic terminals in mouse and rat brain cortex.
Naunyn-Schmiedeberg's archives of pharmacology 1992;345(6):639-46.
1992: Eberhard Schlicker; A Behling; G Lümmen; Manfred Göthert
Histamine H3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex.
Naunyn-Schmiedeberg's archives of pharmacology 1992;345(4):489-93.
1992: Eberhard Schlicker; U Werner; M Hamon; H Gozlan; B Nickel; I Szelenyi; Manfred Göthert
Anpirtoline, a novel, highly potent 5-HT1B receptor agonist with antinociceptive/antidepressant-like actions in rodents.
British journal of pharmacology 1992;105(3):732-8.
1991: B Malinowska; Eberhard Schlicker
H3 receptor-mediated inhibition of the neurogenic vasopressor response in pithed rats.
European journal of pharmacology 1991;205(3):307-10.
1991: D Schneider; Eberhard Schlicker; B Malinowska; Gerhard J Molderings
Noradrenaline release in the rat vena cava is inhibited by gamma-aminobutyric acid via GABAB receptors but not affected by histamine.
British journal of pharmacology 1991;104(2):478-82.
1991: Eberhard Schlicker; G Gross; Klaus Fink; T Glaser; Manfred Göthert
Serotonin release in the rat brain cortex is inhibited by neuropeptide Y but not affected by ACTH1-24, angiotensin II, bradykinin and delta-sleep-inducing peptide.
Naunyn-Schmiedeberg's archives of pharmacology 1991;343(2):117-22.
1991: Manfred Göthert; Gerhard J Molderings; K Fink; Eberhard Schlicker
Heterogeneity of presynaptic serotonin receptors on sympathetic neurones in blood vessels.
Blood vessels 1991;28(1-3):11-8.
1990: Klaus Fink; Eberhard Schlicker; A Neise; Manfred Göthert
Involvement of presynaptic H3 receptors in the inhibitory effect of histamine on serotonin release in the rat brain cortex.
Naunyn-Schmiedeberg's archives of pharmacology 1990;342(5):513-9.
1990: Eberhard Schlicker; Walter Schunack; Manfred Göthert
Histamine H3 receptor-mediated inhibition of noradrenaline release in pig retina discs.
Naunyn-Schmiedeberg's archives of pharmacology 1990;342(5):497-501.
1990: Klaus Fink; Manfred Göthert; Eberhard Schlicker
Veratridine and other depolarizing agents counteract the inhibitory effect of Mg2+ ions on N-methyl-D-aspartate (NMDA)-induced noradrenaline release in vitro.
Naunyn-Schmiedeberg's archives of pharmacology 1990;342(1):53-60.
1990: Eberhard Schlicker; B I Armah; Manfred Göthert
Central presynaptic alpha 2-autoreceptors are involved in the blood pressure-lowering effect of moxonidine.
Journal of cardiovascular pharmacology 1990;16(1):15-22.
1990: A Kohlenbach; Eberhard Schlicker
GABAB receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat.
British journal of pharmacology 1990;100(2):365-9.
1990: E Urbanek; Peter Nickel; Eberhard Schlicker
Antagonistic properties of four suramin-related compounds at vascular purine P2X receptors in the pithed rat.
European journal of pharmacology 1990;175(2):207-10.
1990: Manfred Göthert; Eberhard Schlicker
Identification and classification of 5-HT1 receptor subtypes.
Journal of cardiovascular pharmacology 1990;15 Suppl 7():S1-7.
1989: Eberhard Schlicker; Klaus Fink; M Hinterthaner; Manfred Göthert
Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors.
Naunyn-Schmiedeberg's archives of pharmacology 1989;340(6):633-8.
1989: Eberhard Schlicker; E Urbanek; Manfred Göthert
ATP, alpha,beta-methylene ATP and suramin as tools for characterization of vascular P2x receptors in the pithed rat.
Journal of autonomic pharmacology 1989;9(5):357-66.
1989: Eberhard Schlicker; R Betz; Manfred Göthert
Investigation into the age-dependence of release of serotonin and noradrenaline in the rat brain cortex and of autoreceptor-mediated modulation of release.
Neuropharmacology 1989;28(8):811-5.
1989: Eberhard Schlicker; Klaus Fink; Manfred Göthert; D Hoyer; Gerhard J Molderings; I Roschke; P Schoeffter
The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype.
Naunyn-Schmiedeberg's archives of pharmacology 1989;340(1):45-51.
1989: Gerhard J Molderings; Manfred Göthert; Klaus Fink; E Roth; Eberhard Schlicker
Inhibition of noradrenaline release in the pig coronary artery via a novel serotonin receptor.
European journal of pharmacology 1989;164(2):213-22.
1989: Klaus Fink; Manfred Göthert; Gerhard J Molderings; Eberhard Schlicker
N-methyl-D-aspartate (NMDA) receptor-mediated stimulation of noradrenaline release, but not release of other neurotransmitters, in the rat brain cortex: receptor location, characterization and desensitization.
Naunyn-Schmiedeberg's archives of pharmacology 1989;339(5):514-21.
1988: Eberhard Schlicker; K Erkens; Manfred Göthert
Probable involvement of vascular angiotensin II formation in the beta 2-adrenoceptor-mediated facilitation of the neurogenic vasopressor response in the pithed rat.
Naunyn-Schmiedeberg's archives of pharmacology 1988;338(5):536-42.
1988: Eberhard Schlicker; Gerhard J Molderings; R Betz; Manfred Göthert
Antagonistic properties of RU 24969, a preferential 5-HT1 receptor agonist, at presynaptic alpha 2-adrenoceptors of central and peripheral neurones.
Pharmacology & toxicology 1988;63(4):281-5.
1988: Klaus Fink; Eberhard Schlicker; R Betz; Manfred Göthert
Identification of presynaptic 5-HT1 autoreceptors in pig brain cortex synaptosomes and slices.
Naunyn-Schmiedeberg's archives of pharmacology 1988;338(1):14-8.
1988: Eberhard Schlicker; R Betz; Manfred Göthert
Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex.
Naunyn-Schmiedeberg's archives of pharmacology 1988;337(5):588-90.
1988: Eberhard Schlicker; K Classen; Manfred Göthert
Presynaptic serotonin receptors and alpha-adrenoceptors on central serotoninergic and noradrenergic neurons of normotensive and spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1988;11(5):518-28.
1987: Gerhard J Molderings; Klaus Fink; Eberhard Schlicker; Manfred Göthert
Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava.
Naunyn-Schmiedeberg's archives of pharmacology 1987;336(3):245-50.
1987: Eberhard Schlicker; Klaus Fink; K Classen; Manfred Göthert
Facilitation of serotonin (5-HT) release in the rat brain cortex by cAMP and probable inhibition of adenylate cyclase in 5-HT nerve terminals by presynaptic alpha 2-adrenoceptors.
Naunyn-Schmiedeberg's archives of pharmacology 1987;336(3):251-6.
1987: Manfred Göthert; Eberhard Schlicker; Klaus Fink; K Classen
Effects of RU 24969 on serotonin release in rat brain cortex: further support for the identity of serotonin autoreceptors with 5-HT1B sites.
Archives internationales de pharmacodynamie et de thérapie 1987;288(1):31-42.
1987: Eberhard Schlicker; Manfred Göthert
Presynaptic serotonin receptors on peripheral noradrenergic and central serotoninergic neurons of spontaneously hypertensive and Wistar-Kyoto rats.
Journal of cardiovascular pharmacology 1987;10 Suppl 3():S51-3.
1987: Manfred Göthert; Eberhard Schlicker
Classification of serotonin receptors.
Journal of cardiovascular pharmacology 1987;10 Suppl 3():S3-7.
1985: Eberhard Schlicker; F Brandt; K Classen; Manfred Göthert
Serotonin release in human cerebral cortex and its modulation via serotonin receptors.
Brain research 1985;331(2):337-41.
1984: K Classen; Manfred Göthert; Eberhard Schlicker
Effects of DU 24565 (6-nitroquipazine) on serotoninergic and noradrenergic neurones of the rat brain and comparison with the effects of quipazine.
Naunyn-Schmiedeberg's archives of pharmacology 1984;326(3):198-202.
1984: Eberhard Schlicker; K Classen; Manfred Göthert
GABAB receptor-mediated inhibition of serotonin release in the rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1984;326(2):99-105.